Systemic white blood cell count as a biomarker associated with severity of chronic obstructive lung disease

Tuberculosis and Respiratory Diseases

Volumn 80, Issue 3, 2017, Pages 304-310

  Koo, Hyeon Kyoung ^a   Kang, Hyung Koo ^a   Song, Pamela ^a   Park, Hye Kyeong ^a   Lee, Sung Soon ^a   Jung, Hoon ^a  

^a Inje University College of Medicine   (South Korea)

Author keywords

Chronic obstructive; Leukocyte count; Pulmonary disease; Quality of life; Respiratory function tests

Indexed keywords

ADULT; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SMOKING;

EID: 85026195503     PISSN: 17383536     EISSN: None     Source Type: Journal    
DOI: 10.4046/trd.2017.80.3.304     Document Type: Review

References (23)

1. Roisin RR. Global strategy for the diagnosis, management and prevention of COPD. Updated 2016 [Internet]. Global Initiative for Chronic Obstructive; 2016 [cited 2016 Feb 10]. Available from: http://www.goldcopd.org.
2. Chung KF, Adcock IM. Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur Respir J 2008; 31:1334-56.
3. Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004; 59:574-80.
4. Mannino DM, Valvi D, Mullerova H, Tal-Singer R. Fibrinogen, COPD and mortality in a nationally representative U.S. cohort. COPD 2012; 9:359-66.
5. Dickens JA, Miller BE, Edwards LD, Silverman EK, Lomas DA, Tal-Singer R, et al. COPD association and repeatability of blood biomarkers in the ECLIPSE cohort. Respir Res 2011; 12:146.
6. Walter RE, Wilk JB, Larson MG, Vasan RS, Keaney JF Jr, Lipinska I, et al. Systemic inflammation and COPD: the Framingham Heart Study. Chest 2008; 133:19-25.
7. Singh D, Edwards L, Tal-Singer R, Rennard S. Sputum neutrophils as a biomarker in COPD: findings from the ECLIPSE study. Respir Res 2010; 11:77.
8. Celli BR, Locantore N, Yates J, Tal-Singer R, Miller BE, Bakke P, et al. Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 185:1065-72.
9. Fabbri LM, Luppi F, Beghe B, Rabe KF. Complex chronic comorbidities of COPD. Eur Respir J 2008; 31:204-12.
10. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009; 33:1165-85.
11. Thomsen M, Dahl M, Lange P, Vestbo J, Nordestgaard BG. Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 186:982-8.
12. Van Eeden S, Leipsic J, Paul Man SF, Sin DD. The relationship between lung inflammation and cardiovascular disease. Am J Respir Crit Care Med 2012; 186:11-6.
13. Sode BF, Dahl M, Nordestgaard BG. Myocardial infarction and other co-morbidities in patients with chronic obstructive pulmonary disease: a Danish nationwide study of 7.4 million individuals. Eur Heart J 2011; 32:2365-75.
14. Standardization of spirometry, 1994 update. American Thoracic Society. Am J Respir Crit Care Med 1995; 152:1107-36.
15. Choi JK, Paek D, Lee JO. Normal predictive values of spirometry in Korean population. Tuberc Respir Dis 2005; 58:230-42.
16. EuroQol Group. EuroQol: a new facility for the measurement of health-related quality of life. Health Policy 1990; 16:199-208.
17. Wilke S, Janssen DJ, Wouters EF, Schols JM, Franssen FM, Spruit MA. Correlations between disease-specific and generic health status questionnaires in patients with advanced COPD: a one-year observational study. Health Qual Life Outcomes 2012; 10:98.
18. Rutten-van Molken MP, Oostenbrink JB, Tashkin DP, Burkhart D, Monz BU. Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages? Chest 2006; 130:1117-28.
19. Canavan JL, Dilaver D, Clark AL, Jones SE, Nolan CM, Kon SS, et al. Clinical COPD Questionnaire in patients with chronic respiratory disease. Respirology 2014; 19:1006-12.
20. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112:2735-52.
21. Barnes PJ, Chowdhury B, Kharitonov SA, Magnussen H, Page C P, Postma D, et al. Pulmonary biomarkers in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 174:6-14.
22. Agusti A, Edwards LD, Rennard SI, MacNee W, Tal-Singer R, Miller BE, et al. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One 2012; 7:e37483.
23. Fattouh M, Alkady O. Inflammatory biomarkers in chronic obstructive pulmonary disease. Egypt J Chest Dis Tuberc 2014; 63:799-804.